# 投资设备市场 > IV设备市场研究报告按产品类型（IV导管、IV输液泵、IV输液器、IV配件）、按最终用户（医院、门诊手术中心、居家护理、药店）、按应用（肿瘤学、胃肠病学、心脏病学、神经病学）、按分销渠道（直接销售、第三方分销商、在线销售）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.17% - **2024:** $ 24.12 Billion - **2025:** $ 24.88 Billion - **2035:** $ 34 Billion - **Key Players:** Companies such as Baxter International (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic (US), Smiths Medical (US), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), Nipro Corporation (JP) are some of the major participants in the global market. **Report ID:** MRFR/HC/30920-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/iv-equipment-market-32720 --- ## Market Summary ## IV Equipment Market Overview: As per MRFR analysis, the Iv Equipment Market Size was estimated at 24.12 (USD Billion) in 2024. The Iv Equipment Market Industry is expected to grow from 24.88 (USD Billion) in 2025 to 32.96 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.17% during the forecast period (2025 - 2034). ### Key IV Equipment Market Trends Highlighted An increasing demand for safe and effective delivery methods of medications, fluids, and nutrients to patients is driving the Global IV Equipment Market. Factors such as the rising prevalence of chronic diseases, growing surgical procedures, and an aging population play a significant role in bolstering this demand. Additionally, advancements in technology are leading to more innovative and efficient IV equipment, further enhancing patient care and safety. The emphasis on improving hospital infrastructure and increasing healthcare expenditure is also propelling market growth. Opportunities within the market lie in the development of smart IV equipment that integrates with electronic health records and monitoring systems.There is a growing interest in devices that can provide real-time data analytics and enhance patient outcomes. Companies can also explore the potential in emerging markets where healthcare infrastructure is rapidly improving. This provides a chance to create customized solutions that cater to the specific needs of these regions. Another area of opportunity is the focus on environmentally friendly products as the healthcare sector moves towards sustainable practices. Recent trends indicate a shift towards the use of IV equipment that offers more than basic functionality. For instance, smart pumps that prevent medication errors and devices that allow for remote monitoring are gaining popularity. As awareness of infection control and patient safety increases, the market for IV equipment continues to evolve, adapting to the changing needs of healthcare professionals and patients. The ongoing research and development efforts aim to streamline IV therapy processes further, indicating a promising future for this essential segment of the healthcare industry. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ## IV Equipment Market Drivers ### Increasing Incidence of Chronic Diseases The Global IV Equipment Market Industry is witnessing a significant growth driven by the increasing incidence of chronic diseases across the globe. Conditions such as diabetes, cancer, and cardiovascular diseases are becoming more prevalent, leading to a greater need for intravenous therapies. These health issues often require long-term treatments, which significantly propel the demand for advanced IV equipment. As healthcare providers seek to improve patient outcomes, they are investing in innovative technologies that enhance the delivery of medications through intravenous methods. This growing focus on chronic disease management is also motivating the development of new, more effective IV administration systems. Furthermore, patient education about the benefits of intravenous therapies has heightened healthcare demand, necessitating more efficient solutions to manage treatment processes. Adequate training and resources for healthcare professionals to use IV equipment safely and efficiently are becoming essential. The expanding elderly population, who are particularly susceptible to chronic conditions, further amplifies this demand. ### Technological Advancements in IV Equipment Technological innovations are a critical driver for the Global IV Equipment Market Industry, as advancements in equipment design and functionality enhance the overall patient experience. The development of smart IV pumps and infusion systems that integrate digital monitoring capabilities has gained immense traction. These advanced devices reduce the chances of administration errors and ensure precise dosage delivery, catering to diverse patient needs. Additionally, the advent of automated IV compounding systems has further streamlined the preparation process of IV solutions, leading to improved efficiency and safety in clinical settings. The evolution of mobile and portable IV devices is also expanding the scope of applications, particularly in home healthcare settings. These technological improvements not only attract healthcare providers but also improve patient satisfaction by providing more comfortable and reliable treatment options. ### Rise in Home Healthcare Services The growing trend of home healthcare services is significantly impacting the Global IV Equipment Market Industry. As patients increasingly prefer to receive care at home rather than in traditional healthcare facilities, there is a rising demand for IV equipment suited for home use. This shift is attributed to the desire for greater comfort, reduced healthcare costs, and a personalized approach to treatment. The need for intravenous therapies at home has prompted manufacturers to design user-friendly, safe, and efficient IV devices tailored for non-professional caregivers.With an increasing number of home healthcare agencies entering the market to meet this demand, the Global IV Equipment Market is poised for considerable growth as it evolves to cater to this emerging segment. ## IV Equipment Market Segment Insights: ### IV Equipment Market Product Type Insights   The Global IV Equipment Market revenue is expected to see substantial growth in the coming years, driven by advancements in technology and increasing healthcare needs. In 2023, the IV Catheters segment held a significant share with a market valuation of 8.5 USD Billion, allowing it to dominate the overall landscape of the Global IV Equipment Market segmentation. By 2032, it is projected to grow to 11.5 USD Billion, reflecting a strong need for efficient and reliable intravenous delivery systems. Moreover, IV Infusion Pumps are also gaining traction, with a market valuation of 6.0 USD Billion in 2023, which is expected to increase to 8.0 USD Billion by 2032, underscoring their vital role in managing patient therapies with precision and safety.Meanwhile, IV Sets are valued at 5.5 USD Billion in 2023 and are forecasted to rise to 7.5 USD Billion in 2032, suggesting a steady demand for these essential accessories that facilitate fluid delivery in clinical environments. IV Accessories, while the smallest segment, with a valuation of 2.66 USD Billion in 2023, poised to reach 3.0 USD Billion by 2032, still contributes significantly by enhancing the overall efficiency and safety of intravenous therapies. The interplay of these components showcases a structured approach to patient care, where each segment plays a crucial role in comprehensive treatment strategies, thus driving overall Global IV Equipment Market growth. Growing awareness and focus on healthcare standards also stimulate investments in advanced IV equipment, highlighting an opportunity for further market expansion. With a mix of evolving demands and the necessity for effective treatment methods, the Global IV Equipment Market continues its trajectory toward sustaining growth and innovation in the forthcoming years. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ### IV Equipment Market End User Insights   The Global IV Equipment Market encompasses various end-user categories, playing a crucial role in its overall dynamics. In 2023, the market was valued at approximately 22.66 USD Billion, reflecting the increasing reliance on intravenous therapies across healthcare settings. Hospitals are a major end user, where IV equipment is fundamental for patient care, enhancing treatment efficiency and outcomes. Similarly, Ambulatory Surgical Centers prominently utilize IV equipment for outpatient procedures, highlighting a trend toward minimally invasive techniques.In-Home Care Settings, the demand for IV equipment has surged due to the growing preference for home healthcare solutions, allowing patients to receive treatments in comfort. Pharmacies also represent a significant segment, as they provide essential IV medications and equipment to patients and healthcare providers, thereby facilitating accessibility. The segmentation within the Global IV Equipment Market data illustrates distinct trends and growth drivers, including an aging population and rising chronic diseases, while challenges may stem from regulatory hurdles and cost pressures.Nonetheless, the overall market growth remains positive, driven by the expanding applications and focus on improving patient care across these sectors, as reflected in Global IV Equipment Market statistics. ### IV Equipment Market Application Insights   The Global IV Equipment Market is experiencing notable growth through various application segments, which significantly contribute to its overall landscape. As of 2023, the market was valued at approximately 22.66 billion USD. Key applications like [Oncology](../../../reports/oncology-information-systems-market-7080), Gastroenterology, Cardiology, and Neurology play essential roles in expanding market opportunities. Oncology is a crucial area due to the increasing prevalence of cancer, necessitating advanced IV equipment for treatment delivery. Gastroenterology's demand is driven by digestive disorders, emphasizing the importance of effective medication administration. Cardiology captures a significant portion of the market as cardiovascular diseases continue to rise, creating urgent needs for innovative IV solutions. Neurology remains vital as neurological conditions become more prevalent, highlighting the growing necessity for specialized IV treatments. The overall market's diverse applications cater to a wide range of medical needs, contributing to the Global IV Equipment Market revenue while being aligned with the ongoing trends of personalized medicine and technological advancements. The consistent focus on enhancing patient care and the increasing adoption of IV therapies reflect strong and promising growth in the Global IV Equipment Market statistics. ### IV Equipment Market Distribution Channel Insights   The Global IV Equipment Market revenue reached 22.66 USD Billion in 2023, showcasing a steady progression in market growth driven by innovations and an increasing demand for healthcare services. Within the distribution channel segment of this market, various approaches, including Direct Sales, Third-Party Distributors, and Online Sales, hold significant importance. Direct Sales typically foster closer relationships between manufacturers and healthcare providers, enhancing communication and customer support. Meanwhile, Third-Party Distributors often dominate the market due to their extensive reach and ability to offer a diverse range of products efficiently to various medical facilities.The rise of Online Sales has introduced a transformative era in the IV Equipment Market industry, providing greater accessibility and convenience for purchasing. The overall Global IV Equipment Market segmentation highlights the dynamic nature of these distribution channels, which play a crucial role in ensuring that healthcare providers can easily access necessary intravenous equipment. The demand across these channels continues to grow, bolstered by the need for efficient medical supplies amid the evolving healthcare landscape while maintaining a focus on quality and reliable service provision. ### IV Equipment Market Regional Insights The Global IV Equipment Market shows a strong presence across various regions, with a total market revenue of 22.66 USD Billion in 2023. North America holds a dominant position, valued at 10.0 USD Billion, which signifies its majority holding in the market due to advanced healthcare infrastructure and high demand for IV devices. Europe follows, valued at 6.0 USD Billion, driven by increasing chronic diseases and a growing elderly population, contributing significant growth in this sector. The APAC region, valued at 4.0 USD Billion, is gaining traction due to rapid urbanization and improved healthcare access, making it a significant player in the future. South America and MEA, though smaller in comparison with valuations of 1.5 USD Billion and 1.16 USD Billion, respectively, still represent emerging opportunities for growth as healthcare standards continue to improve, offering the potential for IV equipment penetration. The Global IV Equipment Market data suggests a drive towards enhancing patient care and innovative devices, while challenges include varying regulatory environments and cost pressures impacting market growth across these regions. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ## IV Equipment Market Key Players and Competitive Insights: The Global IV Equipment Market is characterized by a dynamic competitive landscape where companies strive for innovation, quality, and regulatory compliance to meet the diverse needs of healthcare providers. This market includes a wide range of products, such as IV infusion pumps, catheters, and syringes, which are integral to the administration of medications and fluids to patients. With the growing emphasis on patient safety and effective healthcare delivery, companies in this sector are competing not only on product quality but also on technological advancements and the ability to offer comprehensive solutions tailored to various healthcare settings. The response to evolving healthcare standards, along with increasing demand for home healthcare services, has intensified competition among industry players, compelling them to invest in R&D and develop user-friendly products that enhance patient and operator safety.B. Braun Melsungen has established a strong presence in the Global IV Equipment Market through its commitment to innovation and high-quality products. Strengthened by decades of experience in healthcare, B. Braun has developed a comprehensive portfolio of IV solutions that cater to hospitals, clinics, and outpatient facilities. Their products are recognized for incorporating advanced technology, which aims to improve the efficiency of drug delivery systems while minimizing risks associated with IV therapy. The company's focus on patient and healthcare professional safety is reflected in its design philosophy, often leading to industry-first innovations. B. Braun's strategic collaborations with healthcare providers and involvement in various industry initiatives reinforce its position as a leader in the market, allowing the company to stay ahead of emerging trends and address changing consumer needs effectively.Cardinal Health is a prominent player in the Global IV Equipment Market, known for its extensive distribution network and robust product offerings. The company has forged strong relationships with healthcare providers, making it a trusted partner for IV supply solutions. Cardinal Health's strength lies in its ability to provide a wide range of IV equipment alongside essential supply chain management services, ensuring that healthcare facilities have timely access to necessary products. The company continues to invest in enhancing its IV product line, focusing on safety and ease of use, which are critical for improving patient outcomes. Cardinal Health's dedication to compliance with regulatory standards and its commitment to sustainable practices further bolsters its reputation in the market, allowing it to maintain a competitive edge while addressing the evolving demands of the healthcare industry. ### Key Companies in the IV Equipment Market Include: - Braun Melsungen - Cardinal Health - Halyard Health - IV Solutions - Beechwood Pharmaceuticals - Hollister Incorporated - **[Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products.html)** - Stryker Corporation - Vygon - Mindray - Terumo Corporation - Fresenius Kabi - Baxter International - McKesson Corporation - Smiths Medical ## Iv Equipment Industry Developments - **Q2 2024: Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump with Dose IQ Safety Software** Baxter received FDA clearance for its Novum IQ Large Volume Infusion Pump with Dose IQ Safety Software, expanding its smart infusion pump portfolio for intravenous medication delivery in the U.S. - **Q2 2024: B. Braun Launches Spaceplus Infusion Pump System in the United States** B. Braun announced the U.S. launch of its Spaceplus Infusion Pump System, designed to enhance intravenous therapy safety and efficiency in hospital settings. - **Q2 2024: Fresenius Kabi Receives FDA 510(k) Clearance for Agilia Connect Infusion System** Fresenius Kabi received FDA 510(k) clearance for its Agilia Connect Infusion System, enabling advanced connectivity and safety features for intravenous medication administration. - **Q1 2024: Smiths Medical Launches CADD-Solis VIP Ambulatory Infusion Pump** Smiths Medical launched the CADD-Solis VIP Ambulatory Infusion Pump, a new device for intravenous drug delivery in home and ambulatory care settings. - **Q2 2024: ICU Medical Announces FDA Clearance for Plum Duo Infusion Pump** ICU Medical received FDA clearance for its Plum Duo Infusion Pump, a dual-channel intravenous infusion device designed to improve workflow and patient safety. - **Q1 2024: Becton Dickinson acquires infusion pump startup Medovate** Becton Dickinson (BD) acquired Medovate, a UK-based startup specializing in smart intravenous infusion pump technology, to expand its IV equipment portfolio. - **Q2 2024: Baxter Opens New IV Bag Manufacturing Facility in North Carolina** Baxter opened a new intravenous (IV) bag manufacturing facility in North Carolina to increase production capacity and meet growing demand for IV solutions in the U.S. - **Q1 2024: Fresenius Kabi Launches Simplist Micro IV Push Pre-Filled Syringes in Europe** Fresenius Kabi launched its Simplist Micro IV Push pre-filled syringes in select European markets, expanding its intravenous medication delivery product line. - **Q2 2024: B. Braun and Omnicell Announce Strategic Partnership to Integrate Infusion Pump Data with Pharmacy Automation** B. Braun and Omnicell entered a strategic partnership to integrate B. Braun’s infusion pump data with Omnicell’s pharmacy automation systems, aiming to improve intravenous medication management. - **Q1 2024: ICU Medical Completes Acquisition of Pursuit Vascular** ICU Medical completed the acquisition of Pursuit Vascular, a company specializing in IV catheter disinfection technology, to enhance its intravenous therapy safety offerings. - **Q2 2024: Baxter International appoints José Almeida as CEO** Baxter International appointed José Almeida as its new Chief Executive Officer, signaling a leadership change at the global IV equipment manufacturer. - **Q1 2024: BD Launches Next-Generation BD Alaris Infusion System in Canada** Becton Dickinson (BD) launched its next-generation BD Alaris Infusion System in Canada, featuring enhanced safety and interoperability for intravenous medication delivery. ### IV Equipment Market Segmentation Insights ### IV Equipment Market Product Type Outlook - IV Catheters - IV Infusion Pumps - IV Sets - IV Accessories ### IV Equipment Market End User Outlook - Hospitals - Ambulatory Surgical Centers - Home Care Settings - Pharmacies ### IV Equipment Market Application Outlook - Oncology - Gastroenterology - Cardiology - Neurology ### IV Equipment Market Distribution Channel Outlook - Direct Sales - Third-Party Distributors - Online Sales ### IV Equipment Market Regional Outlook - North America - Europe - South America - Asia-Pacific - Middle East and Africa ## Market Drivers ### Rising Prevalence of Chronic Diseases 糖尿病、心血管疾病和癌症等慢性疾病的患病率不断上升是静脉注射设备市场的主要驱动力。由于这些病症通常需要长期治疗和管理，因此对静脉注射疗法的需求可能会增加。根据最新数据，慢性病约占全球死亡人数的 70%，这凸显了有效治疗方案的必要性。   这一趋势迫使医疗保健提供者投资先进的静脉注射设备，以确保高效、安全的药物输送。因此，随着医疗保健系统适应人口老龄化和慢性病负担日益增加的需求，全球行业预计将经历大幅增长。 - 根据 IHME 全球疾病负担研究，非传染性疾病每年占全球死亡人数的 74% 以上，创造了对静脉给药、营养支持和长期治疗管理的持续需求，从而为全球先进静脉注射设备制造商提供了持续增长的机会。 ### Technological Innovations in IV Equipment IV 设备的技术进步正在改变 IV 设备市场的格局。智能等创新[输液泵](https://www.marketresearchfuture.com/reports/infusion-pumps-market-1509)、自动化 IV 系统和先进的导管技术提高了静脉治疗的效率和安全性。例如，配备剂量误差减少系统的智能输液泵变得越来越普遍，从而降低了用药错误的风险。   预计到 2026 年，仅输液泵的全球市场就将达到数十亿美元，显示出强劲的增长轨迹。这些创新不仅改善了患者的治疗效果，还简化了医院的工作流程，使其成为现代医疗保健环境中的重要组成部分。随着技术不断发展，全球行业有望进一步扩张。 - 据 PubMed 称，事实证明，在医疗机构中，采用带有剂量误差减少软件的智能输液泵可将给药错误减少高达 80%，从而促进了技术先进的 IV 设备的日益普及，这些设备旨在提高患者安全和操作效率。 ### Regulatory Compliance and Quality Standards 监管合规性和遵守质量标准是 IV 设备市场的关键驱动力。政府和卫生当局制定了严格的法规，以确保医疗设备（包括静脉输液设备）的安全性和有效性。遵守这些法规不仅可以提高患者的安全，还可以增强医疗保健提供者和患者之间的信任。    全球市场必须应对复杂的监管环境，而不同地区的监管环境可能存在很大差异。然而，成功满足这些标准的公司可能会获得竞争优势。对质量保证和监管合规性的重视预计将影响行业内的产品开发和创新，最终有利于患者护理。 - 根据世界银行的数据，全球当前卫生支出达到约 9.8 万亿美元，反映出对优质医疗保健系统和监管框架的持续投资。对患者安全和医疗设备质量的日益关注支持了全球医疗机构采用合规的高性能 IV 设备。 ### Growing Investment in Healthcare Infrastructure 医疗保健基础设施投资是静脉输液设备市场的重要驱动力。随着各国努力改善医疗保健系统，人们齐心协力改善设施、扩大服务和升级医疗设备。这种趋势在新兴市场尤其明显，这些国家的政府正在增加医疗保健支出，以满足不断增长的人口的需求。   例如，对医院和诊所的投资预计将大幅增加，导致对静脉注射设备的需求增加。全球市场将从这些投资中受益，因为医疗保健提供商寻求为其设施配备最新技术，以改善患者护理和运营效率。 - 根据世界银行的数据，全球当前卫生支出约占全球 GDP 的 9.9%，凸显了对医疗基础设施扩建、医院现代化和医疗设备采购的大量投资，所有这些都对静脉注射设备需求的增长做出了积极贡献。 ### Increasing Demand for Home Healthcare Solutions 家庭医疗保健的增长趋势正在显着影响静脉输液设备市场。受便利性、成本效益和生活质量提高等因素的推动，患者越来越喜欢在舒适的家中接受治疗。这种转变需要开发可在传统医疗环境之外使用的便携式且用户友好的静脉注射设备。   市场数据显示，未来几年家庭医疗保健市场预计将以超过7%的年复合增长率增长。因此，制造商专注于创建适合家庭使用的创新静脉注射解决方案，从而扩大其市场范围并满足患者不断变化的需求。 - 据 PubMed 称，多项临床研究表明，家庭输液治疗项目的患者满意度超过 90%，支持了向家庭医疗保健的更广泛过渡，并推动了对专为非医院环境设计的便携式、易于使用的静脉注射设备的需求。 ## Future Outlook IV设备市场预计将在2024年至2035年间以3.17%的年均增长率增长，推动因素包括技术进步、日益增长的医疗需求和改善的患者护理解决方案。 **New opportunities:** - 开发集成监测系统的智能静脉输液泵。 到2035年，静脉输液设备市场预计将保持强劲，反映出持续的增长和创新。 ## Segment Insights ### 按产品类型：IV 导管（最大）与 IV 输液泵（增长最快） 在静脉注射设备市场中，静脉注射导管因其在促进患者静脉通路方面发挥的关键作用而占据最大的市场份额，达 58.4%。该细分市场受益于医疗保健环境中的广泛应用，从紧急护理到常规程序。静脉输液泵很快成为重要参与者，展示了卓越的适应性和技术进步，吸引了寻求精确和轻松的患者护理的医疗保健提供者。这些产品是有效输送药物、液体和营养不可或缺的一部分。当前的增长趋势表明，由于对自动化解决方案的需求不断增长以及增强患者安全的需求，静脉输液泵领域将经历最快的增长。监管的进步、住院人数的增加和人口老龄化是推动这一领域向前发展的关键因素。智能输液系统和改进的连接功能等技术创新进一步促进了医疗保健领域输液泵的增长。 得益于其广泛的血管通路和输液治疗产品组合，百特国际创造了约 148 亿美元的收入。该公司对导管技术的持续投资与不断增长的手术量相一致，并巩固了静脉导管在全球医院和医疗机构中的领先地位。 ### 按最终用户：医院（最大）与家庭护理机构（增长最快） 在静脉注射设备市场中，医院由于患者护理中对静脉注射疗法的广泛需求而在最终用户领域占据主导地位。医院所占份额最大，为 67.2%，反映了医院对多样化静脉设备的持续需求，以管理大量患者。另一方面，门诊手术中心和药房所占份额较小，但它们是提供静脉注射治疗的不可或缺的组成部分，特别是在门诊环境中。该细分市场的增长趋势受到多种因素的影响，包括需要长期静脉注射治疗的慢性疾病患病率的增加以及外科手术数量的增加。家庭护理环境被认为是增长最快的部分，其推动因素是向门诊护理的转变以及患者偏好在自己舒适的家中接受治疗。静脉注射技术的进步进一步支持了这一趋势，提高了患者在家的安全性和便利性。 B. Braun Melsungen AG 公布的年收入约为 91 亿欧元，反映出医院医疗保健服务的强劲需求。住院人数、重症监护需求和静脉治疗利用率的增加继续加强了医院在静脉注射设备市场的主导地位。 ### 按应用分类：肿瘤学（最大）与心脏病学（增长最快） 在IV设备市场中，应用领域呈现出多样化的市场份额分布。由于癌症患病率不断上升以及对有效治疗解决方案的需求，肿瘤学成为最大的细分市场。该细分市场包括专为癌症患者设计的各种静脉注射疗法，占据了 34.6% 的市场份额。相比之下，胃肠病学和神经病学是较小的细分市场，但有助于静脉注射市场应用的整体多样性，因其特定的治疗要求和创新而引起人们的关注。 肿瘤学：占主导地位 vs. 心脏病学：新兴 肿瘤学是静脉注射设备市场的主导应用，其特点是其在癌症治疗的管理中发挥着重要作用。该细分市场受益于针对化疗和支持性护理量身定制的静脉注射解决方案的明确需求。另一方面，心脏病学正在迅速兴起，反映出心血管疾病的增加和治疗方法的进步推动了显着的增长。 Cardiology 专注于用于液体管理和药物输送等治疗的创新静脉注射设备，这正在推动其市场占有率。这两个细分市场都凸显了市场不断变化的格局，表现出独特的特征和增长潜力。 ### 按分销渠道：直销（最大）与在线销售（增长最快） 在静脉输液设备市场，不同渠道的市场份额分布明显偏向直销，目前占比最大，为61.5%。这种主导地位是由医疗机构和医疗保健提供者更喜欢直接购买 IV 设备以确保质量、可靠性和售后支持而推动的。第三方分销商也构成了一个值得注意的细分市场，提供了额外的覆盖范围和服务选项，但它们被在线销售日益增长的偏好所掩盖，而在线销售自大流行以来就受到了关注。静脉输液设备分销渠道的增长趋势明显受到医疗保健领域电子商务和数字解决方案兴起的影响。受益于便利性的提高、轻松比较产品的能力以及数字健康平台的扩展，在线销售正在成为增长最快的渠道。相反，虽然直销仍然占主导地位，但随着越来越多的机构探索将在线购买与传统方法相结合的混合模式，直销正在逐渐发生转变。这种演变反映了更广泛的医疗保健消费趋势，其中效率和即时性越来越受到重视。 直销（主导）与第三方分销商（新兴） 静脉注射设备市场的直销渠道的特点是制造商和医疗保健提供商之间建立了牢固的长期关系，确保了高质量设备和个性化服务的稳定流动。对于提供在销售过程中需要技术知识和支持的专业产品的公司来说，这种主导地位至关重要。相比之下，第三方分销商代表了一个新兴的细分市场，它通过将制造商的影响范围扩展到更广阔的市场来补充直销。这些分销商可以提供有竞争力的价格和各种设备选择，吸引较小的医疗机构或新的市场进入者。尽管仍仅次于直销，但第三方分销商的敏捷性和服务灵活性使其成为快速发展的医疗保健领域中有吸引力的替代方案。 ## Regional Market Share Analysis 北美在静脉输液设备市场规模方面处于领先地位，2024年将占全球收入的40.22%以上，这意味着由于先进的医疗基础设施和对静脉输液设备的高需求，北美在该市场占据了主导地位。 - 根据 CDC 数据，大约 1.29 亿美国人患有至少一种主要慢性病，这创造了对静脉注射疗法、输液服务和医院治疗项目的持续需求，这些需求支撑了北美在静脉注射设备市场的领导地位。 2024年欧洲IV设备市场规模为60亿美元，成为第二大区域市场，份额为24.88%。 - 欧洲药品管理局支持医疗保健生态系统，为欧盟超过 4.48 亿人提供服务，促进医疗产品和静脉疗法的高标准。这种强有力的监管环境继续鼓励采用先进的静脉注射设备，并支持整个欧洲市场的持续增长。 价值 40 亿美元的亚太地区由于快速的城市化和医疗保健的改善而受到关注，使其成为未来的重要参与者。 南美洲和中东和非洲地区的估值虽然分别小于 15 亿美元和 1.16 亿美元，但随着医疗保健标准的不断提高，仍然代表着新兴的增长机会，为静脉注射设备的渗透提供了潜力。全球静脉注射设备市场数据表明，人们正在推动加强患者护理和创新设备，但挑战包括不同的监管环境和影响这些地区市场增长的成本压力。 ## Competitive Benchmarking 全球静脉注射设备行业的特点是竞争格局动态，各公司努力创新、质量和合规性，以满足医疗保健提供者的多样化需求。该市场包括各种产品，例如静脉输液泵、导管和注射器，这些产品是向患者给药和输液不可或缺的一部分。随着对患者安全和有效医疗保健服务的日益重视，该行业的公司不仅在产品质量上进行竞争，而且还在技术进步和提供针对各种医疗保健环境的综合解决方案的能力上进行竞争。    对不断发展的医疗保健标准的响应，以及对家庭医疗保健服务的需求不断增加，加剧了行业参与者之间的竞争，迫使他们投资于研发并开发用户友好的产品，以提高患者和操作员的安全。 Braun Melsungen 通过致力于创新和高质量产品，在全球 IV 设备市场上建立了强大的影响力。凭借数十年的医疗保健经验，贝朗开发了全面的静脉注射解决方案组合，以满足医院、诊所和门诊设施的需求。   他们的产品因采用先进技术而受到认可，旨在提高药物输送系统的效率，同时最大限度地降低与静脉注射治疗相关的风险。该公司对患者和医疗保健专业安全的关注体现在其设计理念中，通常会带来行业领先的创新。贝朗与医疗保健提供商的战略合作以及对各种行业计划的参与巩固了其作为全球市场领导者的地位，使该公司能够领先于新兴趋势并有效满足不断变化的消费者需求。康德乐是全球 IV 设备市场的重要参与者，以其广泛的分销网络和强大的产品供应而闻名。    该公司与医疗保健提供商建立了牢固的关系，使其成为静脉注射供应解决方案值得信赖的合作伙伴。康德乐的优势在于能够提供广泛的静脉注射设备以及基本的供应链管理服务，确保医疗机构能够及时获得必要的产品。该公司继续投资增强其静脉注射产品线，重点关注安全性和易用性，这对于改善患者的治疗效果至关重要。康德乐致力于遵守监管标准以及对可持续实践的承诺，进一步提升了其在全球市场的声誉，使其能够在满足医疗保健行业不断变化的需求的同时保持竞争优势。 ## Recent News & Developments - **2024 年第二季度：百特宣布美国 FDA 批准配备 Dose IQ 安全软件的 Novum IQ 大容量输液泵**百特 (Baxter) 的 Novum IQ 大容量输液泵和 Dose IQ 安全软件获得 FDA 批准，扩大了其在美国静脉注射药物的智能输液泵产品组合。 - **2024 年第二季度：贝朗在美国推出 Spaceplus 输液泵系统**贝朗宣布在美国推出 Spaceplus 输液泵系统，旨在提高医院环境中静脉治疗的安全性和效率。 - **2024 年第二季度：Fresenius Kabi 的 Agilia Connect 输液系统获得 FDA 510(k) 许可**Fresenius Kabi 的 Agilia Connect 输液系统获得 FDA 510(k) 许可，为静脉给药提供先进的连接和安全功能。 - **2024 年第一季度：Smiths Medical 推出 CADD-Solis VIP 流动输液泵**Smiths Medical 推出了 CADD-Solis VIP 动态输液泵，这是一种用于家庭和门诊护理环境中静脉注射药物的新设备。 - **2024 年第二季度：ICU Medical 宣布 FDA 批准 Plum Duo 输液泵**ICU Medical 的 Plum Duo 输液泵获得 FDA 批准，这是一种双通道静脉输液设备，旨在改善工作流程和患者安全。 - **2024 年第一季度：Becton Dickinson 收购输液泵初创公司 Medovate**Becton Dickinson (BD) 收购了专门从事智能静脉输液泵技术的英国初创公司 Medovate，以扩大其 IV 设备产品组合。 - **2024 年第二季度：百特在北卡罗来纳州开设新的静脉输液袋制造工厂**百特在北卡罗来纳州开设了一家新的静脉注射 (IV) 袋制造工厂，以提高产能并满足美国对静脉注射解决方案不断增长的需求。 - **2024 年第一季度：Fresenius Kabi 在欧洲推出 Simplist Micro IV Push 预填充注射器**Fresenius Kabi 在部分欧洲市场推出了 Simlist Micro IV Push 预充注射器，扩大了其静脉给药产品线。 - **2024 年第二季度：B. Braun 和 Omnicell 宣布建立战略合作伙伴关系，将输液泵数据与药房自动化集成**B. Braun 和 Omnicell 建立战略合作伙伴关系，将 B. Braun 的输液泵数据与 Omnicell 的药房自动化系统集成，旨在改善静脉药物管理。 - **2024 年第一季度：ICU Medical 完成对 Pursuit Vascular 的收购**ICU Medical 完成了对 Pursuit Vascular（一家专门从事静脉导管消毒技术的公司）的收购，以增强其静脉治疗安全产品。 - **2024 年第二季度：百特国际任命何塞·阿尔梅达 (José Almeida) 为首席执行官**百特国际任命何塞·阿尔梅达为其新任首席执行官，标志着这家全球静脉输液设备制造商的领导层发生了变化。 - **2024 年第一季度：BD 在加拿大推出下一代 BD Alaris 输液系统**Becton Dickinson (BD) 在加拿大推出了新一代 BD Alaris 输液系统，该系统具有增强的静脉药物输送安全性和互操作性。 ### IV设备市场细分洞察 ### IV设备市场产品类型展望 - 四号[导管](https://www.marketresearchfuture.com/reports/catheters-market-3186) - 静脉输液泵 - 静脉输液套件 - 四、配件 ### IV设备市场最终用户展望 - 医院 - 门诊手术中心 - 家庭护理设置 - 药房 ### IV设备市场应用展望 - 肿瘤学 - 胃肠病学 - 心脏病学 - 神经病学 ### IV设备市场分销渠道展望 - 直销 - 第三方经销商 - 网上销售 ### IV设备市场区域展望 - 北美 - 欧洲 - 南美洲 - 亚太 - 中东和非洲 ## Report Scope | 2024年市场规模 | 241.2（亿美元） | | --- | --- | | 2025年市场规模 | 248.8（亿美元） | | 2035年市场规模 | 340.0（亿美元） | | 复合年增长率（CAGR） | 3.17%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 亿美元 | | 主要公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 主要市场机会 | 智能技术在静脉设备中的整合增强了患者监测和安全性。 | | 主要市场动态 | 对先进静脉设备的需求上升推动了医疗行业制造商之间的创新和竞争。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 到2035年，IV设备市场的预计市场估值是多少？** A: IV设备市场预计到2035年将达到340亿美元的估值。 **Q: 2024年IV设备市场的市场估值是多少？** A: 2024年，IV设备市场的价值为241.2亿美元。 **Q: 在2025年至2035年的预测期内，IV设备市场的预期CAGR是多少？** A: 在2025年至2035年的预测期内，IV设备市场的预期CAGR为3.17%。 **Q: 到2035年，预计哪个产品细分市场的估值最高？** A: 到2035年，IV输液泵细分市场预计将达到100亿美元的估值。 **Q: IV设备市场的关键参与者有哪些？** A: IV设备市场的主要参与者包括百特国际公司、B. Braun Melsungen AG和费森尤斯卡比AG。 **Q: 到2035年，IV导管细分市场预计将达到多少价值？** A: 预计到2035年，IV导管细分市场的价值将达到80亿美元。 **Q: 到2035年，家庭护理设置部门的预期估值是多少？** A: 到2035年，居家护理设置部门预计将达到60亿美元的估值。 **Q: 到2035年，预计哪个应用领域的增长幅度最大？** A: 心脏病学应用领域预计到2035年将增长至100亿美元的估值。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/iv-equipment-market-32720*